<DOC>
	<DOCNO>NCT00040625</DOCNO>
	<brief_summary>This study evaluate effect ( good bad ) ALIMTA Cisplatin ALIMTA alone malignant pleural mesothelioma well make ALIMTA available patient qualify treatment .</brief_summary>
	<brief_title>ALIMTA ( Pemetrexed ) Alone Combination With Cisplatin Patients With Malignant Mesothelioma .</brief_title>
	<detailed_description />
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Have prove diagnosis malignant mesothelioma patient candidate curative surgery Prior chemotherapy disease allow Measurable lesion require Have adequate performance status Sign inform consent form You exclude trial receive investigational agent within 4 week enrol study You exclude trial receive radiation within previous 2 week You exclude trial candidate curative surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
</DOC>